Similar increases in NK cell-mediated cytotoxicity were observed across various NK cell-to-cancer cell ratios in both EHMT2 inhibitor-treated UM cells and UM cells expressing EHMT2 shRNAs (Appendix Fig. S2B,C). The gene discussed is EHMT2; the disease is cancer.